Seminars in Perinatology
Volume 31, Issue 4 , Pages 227-231 , August 2007

Management of Thromboembolism in Pregnancy

  • Peter W. Marks, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Peter W. Marks, MD, PhD, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208021, New Haven, CT 06520-8021.

References 

  1. Robertson L, Wu O, Langhorne P. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132:171–196
  2. Lim W, Eikelboom JW, Ginsberg JS. Inherited thrombophilia and pregnancy associated venous thromboembolism. Br Med J. 2007;334:1318–1321
  3. Khare M, Nelson-Piercy C. Acquired thrombophilias and pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003;17:491–507
  4. Biron-Andreani C, Schved JF, Daures JP. Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis. Thromb Haemost. 2006;96:14–18
  5. Haemostasis and Thrombosis Task ForceBritish Committee for Standards in Haematology. Investigation and management of heritable thrombophilia. Br J Haematol. 2001;114:512–528
  6. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol. 2002;99:333–341
  7. Astedt B. Antenatal drugs affecting vitamin K status of the fetus and the newborn. Semin Thromb Hemost. 1995;21:364–370
  8. Bates SM, Ginsberg JS. How we manage venous thromboembolism during pregnancy. Blood. 2002;100:3470–3478
  9. Barbour LA ACOG Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin: Thromboembolism in pregnancy. Int J Gynaecol Obstet. 2001;75:203–212
  10. Krivak TC, Zorn KK. Venous thromboembolism in obstetrics and gynecology. Obstet Gynecol. 2007;109:761–777
  11. de Swiet M. Management of pulmonary embolus in pregnancy. Eur Heart J. 1999;20:1378–1385
  12. Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv. 1995;50:534–541
  13. Phillips OP. Venous thromboembolism in the pregnant patient. J Reprod Med. 2003;48(suppl):921–929
  14. Ageno W, Crotti S, Turpie AG. The safety of antithrombotic therapy during pregnancy. Expert Opin Drug Saf. 2004;3:113–118
  15. Grand’Maison A, Charest AF, Geerts WH. Anticoagulant use in patients with renal impairment. Am J Cardiovasc Drugs. 2005;5:291–305
  16. Bates SM, Greer IA, Hirsh J, et al. Use of antithrombotic agents during pregnancy. Chest. 2004;126:627S–644S
  17. Michota F, Merli G. Anticoagulation in special patient populations: are special dosing considerations required?. Cleve Clin J Med. 2005;72(suppl 1):S37–S42
  18. Gris J-C, Lissalde-Lavigne G, Quére I, et al. Monitoring the effects and managing the side effects of anticoagulation during pregnancy. Obstet Gynecol Clin North Am. 2006;33:397–411
  19. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28:172–197
  20. Nelson-Piercy C. Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis. Baillieres Clin Obstet Gynaecol. 1997;11:489–509
  21. Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med. 2007;356:2653–2654
  22. Lindhoff-Last E, Bauersachs R. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation. Semin Thromb Hemost. 2002;28:439–446

PII: S0146-0005(07)00077-8

doi: 10.1053/j.semperi.2007.07.010

Seminars in Perinatology
Volume 31, Issue 4 , Pages 227-231 , August 2007

Article Tools

* Image Usage & Resolution